All abstracts
Home
Scientific Programme
Industry Sessions
Live Sessions
Abstracts
E-posters
Sponsors and Exhibitors
All
Posters
Topics
Presentation Type
Loading
Clear all filters
EPP124
Diminishing Loss Sensitivity during Risky Decision-Making among Individuals with Gambling Disorder
EPP125
Association Between Problematic Internet Use, Autistic Traits, and Psychological Distress Among Adults: a Cross-Sectional Survey
EPP126
Population Pharmacogenetic-Pharmacokinetic Approach in the Context of Methadone Administration in Galicia, Spain
EPP127
Evolution and Management of Cognitive Disorders Related to Chronic Cannabis Use: A Literature Review
EPP128
Risk Factors for Cognitive Impairments in Chronic Cannabis Use: A Systematic Review
EPP129
Substance-Induced Psychosis and First-Episode Psychotic Disorders: Premorbid Risks, Labour Market Outcomes, and Antipsychotic Use
EPP130
Impact of cannabis decriminalization on selected psychotic disorders: a retrospective analysis at the Center for Mental Health and Prevention of Addiction (2013–2023) in Tbilisi
EPP131
Drug Abuse Problems are Associated with Poorer Health-Related Quality of Life
EPP132
Non-stimulant pharmacotherapy for ADHD in adults with comorbid substance use disorders: a review of randomized trials
EPP133
Assessment of Adverse Childhood Experiences & Resilience in Adults With Substance Use Disorders & Healthy Controls: A Case-Control Study
EPP134
Changes in Self-Reported Hunger Among Patients in Heroin-Assisted Treatment in Norway
EPP135
Screening for Substance Use Disorders in Primary Care Settings: A Systematic Review
EPP136
Prescription stimulants for Medication-assisted treatment of Cocaine Use Disorder: A Case study and review of literature
EPP137
Longitudinal disturbances of objective sleep architecture in cocaine use disorder: A translational systematic review
EPP138
Pattern of stimulants abuse among adolescents and associated risk
EPP139
D2 Partial Agonists vs Full Antagonists in Young Adults with Early SMI and Co-Occurring Substance Use
EPP140
Diplotype-Guided Differences in Alcohol Withdrawal Severity Under Diazepam Therapy
EPP141
Polysubstance use among patients receiving opioid agonist maintenance treatment in Belarus: source-dependent underreporting and implications for care
EPP142
Sex-Specific Temporal Patterns of Comorbid Mental, Behavioral, and Somatic Diagnoses Relative to Substance Use Disorder Onset: Evidence from the Norwegian Patient Registry
EPP143
Randomized clinical trial of a novel food insecurity intervention for patients with opioid use disorder: Unexpected improvements in depression, quality of life and pain outcomes
1864
abstracts
1
...
5
6
7
8
...
94